Sycamore Partners completes acquisition of Walgreens Boots Alliance.
PorAinvest
jueves, 28 de agosto de 2025, 9:20 am ET1 min de lectura
WBA--
Following the closing of the transaction, Walgreens, The Boots Group, Shields Health Solutions, CareCentrix, and VillageMD will operate as separate standalone companies. The acquisition has resulted in WBA's common stock ceasing trading and no longer being listed on the Nasdaq. In addition to the cash consideration of $11.45 per WBA share, shareholders will receive one non-transferable right to receive up to an additional $3.00 in cash per WBA share from the net proceeds of the future monetization of WBA’s debt and equity interests in VillageMD, which includes the Village Medical, Summit Health, and CityMD businesses.
Stefano Pessina expressed his family's continued commitment to the companies, stating, "This milestone begins a new chapter for Walgreens, The Boots Group, and the other portfolio businesses. Our family has proudly supported these companies for decades, and we are pleased to continue that commitment alongside Sycamore."
Stefan Kaluzny, Managing Director of Sycamore, emphasized the importance of the companies' role in their communities and the potential for growth under private ownership. "Walgreens Boots Alliance, Inc., its companies, and its dedicated team members play an essential role in the communities they serve around the world. We look forward to partnering with the management teams at each company," Kaluzny said.
The acquisition was advised by UBS Investment Bank, Goldman Sachs, J.P. Morgan, Citi, Wells Fargo, Davis, Polk & Wardwell LLP, Bass Berry & Sims PLC, Centerview Partners, Kirkland & Ellis LLP, Ropes & Gray LLP, Debevoise & Plimpton LLP, and Morgan Stanley & Co. LLC.
References:
[1] https://www.morningstar.com/news/business-wire/20250827891313/sycamore-partners-completes-acquisition-of-walgreens-boots-alliance
[2] https://www.nasdaq.com/press-release/sycamore-partners-completes-acquisition-walgreens-boots-alliance-2025-08-28
Sycamore Partners has completed its acquisition of Walgreens Boots Alliance (WBA) in partnership with Stefano Pessina and his family. The acquisition allows WBA to operate as standalone companies, including Walgreens, The Boots Group, Shields Health Solutions, CareCentrix, and VillageMD. Sycamore Partners is acquiring the business with the goal of partnering with management teams to drive growth and expansion.
Sycamore Partners has successfully completed its acquisition of Walgreens Boots Alliance (WBA) in partnership with Stefano Pessina and his family. The acquisition allows WBA to operate as standalone companies, including Walgreens, The Boots Group, Shields Health Solutions, CareCentrix, and VillageMD. Sycamore Partners is acquiring the business with the goal of partnering with management teams to drive growth and expansion.Following the closing of the transaction, Walgreens, The Boots Group, Shields Health Solutions, CareCentrix, and VillageMD will operate as separate standalone companies. The acquisition has resulted in WBA's common stock ceasing trading and no longer being listed on the Nasdaq. In addition to the cash consideration of $11.45 per WBA share, shareholders will receive one non-transferable right to receive up to an additional $3.00 in cash per WBA share from the net proceeds of the future monetization of WBA’s debt and equity interests in VillageMD, which includes the Village Medical, Summit Health, and CityMD businesses.
Stefano Pessina expressed his family's continued commitment to the companies, stating, "This milestone begins a new chapter for Walgreens, The Boots Group, and the other portfolio businesses. Our family has proudly supported these companies for decades, and we are pleased to continue that commitment alongside Sycamore."
Stefan Kaluzny, Managing Director of Sycamore, emphasized the importance of the companies' role in their communities and the potential for growth under private ownership. "Walgreens Boots Alliance, Inc., its companies, and its dedicated team members play an essential role in the communities they serve around the world. We look forward to partnering with the management teams at each company," Kaluzny said.
The acquisition was advised by UBS Investment Bank, Goldman Sachs, J.P. Morgan, Citi, Wells Fargo, Davis, Polk & Wardwell LLP, Bass Berry & Sims PLC, Centerview Partners, Kirkland & Ellis LLP, Ropes & Gray LLP, Debevoise & Plimpton LLP, and Morgan Stanley & Co. LLC.
References:
[1] https://www.morningstar.com/news/business-wire/20250827891313/sycamore-partners-completes-acquisition-of-walgreens-boots-alliance
[2] https://www.nasdaq.com/press-release/sycamore-partners-completes-acquisition-walgreens-boots-alliance-2025-08-28
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema



Comentarios
Aún no hay comentarios